Private Trust Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Private Trust Company’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,244	Closed	-$99.7K	–	2333
2024 Q1	$99.7K	Buy	+1,244	New	+$96.4K	0.01%	872
2016 Q1	–	Sell	-7,755	Closed	-$542K	–	322
2015 Q4	$542K	Hold	7,755	–	–	0.15%	172
2015 Q3	$514K	Hold	7,755	–	–	0.15%	173
2015 Q2	$607K	Sell	7,755 -2,000	-21%	-$156K	0.17%	154
2015 Q1	$745K	Buy	9,755 +2,786	+40%	+$205K	0.21%	129
2014 Q4	$463K	Sell	6,969 -200	-3%	-$13.3K	0.15%	183
2014 Q3	$456K	Hold	7,169	–	–	0.15%	161
2014 Q2	$438K	Hold	7,169	–	–	0.14%	166
2014 Q1	$406K	Buy	7,169 +400	+6%	+$22.7K	0.15%	161
2013 Q4	$362K	Buy	6,769 +1,604	+31%	+$80.3K	0.15%	158
2013 Q3	$238K	Buy	5,165 +4,989	+2,835%	+$228K	0.11%	192
2013 Q2	$7K	Buy	+176	New	+$7.33K	﹤0.01%	971

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Private Trust Company's PJP Position: Q2 2024 in Review

Private Trust Company sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2024, closing a stake of 1,244 shares — an estimated $99.7K sold.

Private Trust Company first reported a position in PJP in Q2 2013 and held it in 12 quarters. The position peaked at $745K in Q1 2015. 89 funds tracked by Wall St. Rank hold PJP as of Q2 2024.

Private Trust Company reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
Private Trust Company sold 1,244 Invesco Pharmaceuticals ETF shares in Q2 2024, an estimated $99.7K.
Private Trust Company first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 12 quarters.
Private Trust Company's Invesco Pharmaceuticals ETF position peaked at $745K in Q1 2015.
89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2024.

Based on Private Trust Company's 13F filing for Q2 2024, filed 23 Jul 2024.